Overview

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the proportion of subjects with HIV-1 RNA viral load < 50 c/mL through Week 48 of the Maintenance Phase among HIV-infected subjects with an initial undetectable viral load following an Induction Phase with an ATV/RTV containing HAART regimen, when switched to ATV versus remaining on ATV/RTV, whilst continuing their previous NRTI backbone.
Phase:
Phase 4
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Atazanavir Sulfate
Ritonavir